rector of Oncologic Imaging at Cross Cancer Institute, and Director of Division of Oncologic Imaging, Department of Oncology, University of Alberta

  • Andrew Raubitschek, M.D., Chair, City of Hope National Medical Center

  • Peter Carroll, M.D., Co-Director of Urologic Oncology Service, and Chair of Urology Department, University of California at San Francisco

  • Keith McCormick, M.B.A., Senior Manager, Oncology Marketing, Biogen-IDEC

  • Combining In Vitro and In Vivo Diagnostics via a Systems Biology Foundation, James Heath, Ph.D., Professor of Chemistry, California Institute of Technology

  • Micro- and Nanotechnologies for Accelerated Access to Biological Information, Michael Ramsey, Ph.D., Minnie N. Goldby Distinguished Professor of Chemistry Chair, University of North Carolina

  • Biological Large Scale Integration, Stephen Quake, Ph.D., Professor of Bioengineering, Stanford University

A.5
FIFTH MEETING, JANUARY 6–7, 2007, WASHINGTON, D.C.

The objective of the fifth meeting was to gather information on further sponsor perspective and regulatory hurdles facing the field of nuclear medicine. The following is the list of speakers for the open session:

  • Michael Viola, M.D., Director, Life and Medicine Sciences Division, DOE

  • John Pantaleo, M.S., Director, Isotope Programs, DOE

  • Belinda Seto, Ph.D., Deputy Director, NIBIB, NIH

  • George Mills, M.D., Director, Division of Medical Imaging & Hematology Products, Food and Drug Administration

A.6
SIXTH MEETING, FEBRUARY 19–20, 2007, WASHINGTON, D.C.

The objective of the sixth meeting was to gather information on developments at the DOE-Nuclear Energy’s Isotope Programs. The following is the list of speakers for the open session:

  • John Pantaleo, M.S., Director, Isotope Programs, DOE

  • Darrell Fisher, Ph.D., Scientific Director, Pacific Northwest National Laboratory



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement